Vitalhub (TSE:VHI) has released an update.
VitalHub Corp. is set to acquire MedCurrent Corporation, aiming to enhance healthcare delivery by integrating MedCurrent’s Clinical Decision Support (CDS) software, OrderWise, into their services. This move is expected to reduce unnecessary medical tests and procedures, thereby lowering healthcare costs and improving patient care. The acquisition, valued at up to C$34 million, will make MedCurrent a wholly owned subsidiary of VitalHub.
For further insights into TSE:VHI stock, check out TipRanks’ Stock Analysis page.
